Galmed Pharmaceuticals Ltd
10 clinical trials · Sponsor
◉ Watch Galmed Pharmaceuticals Ltd
| Record | Firm | Date |
|---|---|---|
| Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet (NCT07251712) | Galmed Pharmaceuticals Ltd | 2025-12-25 |
| A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis (NCT06095986) | Galmed Pharmaceuticals Ltd | 2025-06-01 |
| A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects (NCT05857215) | Galmed Pharmaceuticals Ltd | 2021-03-05 |
| An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol (NCT05874336) | Galmed Pharmaceuticals Ltd | 2020-06-17 |
| Comparison of Aramchol Concentrations With Once or Twice Daily Dosing (NCT03774173) | Galmed Pharmaceuticals Ltd | 2018-12-08 |
| Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy Volunteers (NCT03760848) | Galmed Pharmaceuticals Ltd | 2018-11-12 |
Track Galmed Pharmaceuticals Ltd automatically
Every clearance here is in the API, with alerts when new ones post.